Facilities
/ Manufacturing Plant

Facility
& Capacity

Our primary and secondary packaging operations are designed to support both high-volume commercial production and small, specialized batches— always with the same commitment to quality and flexibility.

Location


GETAFE
Spain

Annual capacity

Up to 600 MILLION UNITS PER YEAR

Out-licensing (vademécum)

  • Ophthalmology
  • Respiratory
Product Intended use Clasification Regulation Format
Saline Solution (Isotonic) Solution intended for nasal irrigation and eye rewetting. Contact lens care solutions. MD (llb) MDR 2, 5, 10 ml
Buffered Saline Solution (Isotonic) Solution intended for nasal irrigation and eye rewetting. Contact lens care solutions. MD (llb) MDR 5 ml
Wetting Solution (HA 0.1%) Solution intended for eye and contact lenses rewetting. MD (llb) MDR 0.4 ml
Saline Solution 0.9% (Isotonic) Solution intended for nasal irrigation, inhalation and eye rewetting. Irrigation solution for wound care. MD (lla) MDD 2.5, 5 ml
Saline Solution 0.9% + HA (Isotonic) Inhalation solution. MD (lla) MDD 5 ml
Saline Solution 1.5% (Hypertonic) Inhalation solution. MD (lla) MDD 5 ml
Saline Solution 3% (Hypertonic) Inhalation solution. MD (lla) MDD 5 ml
Saline Solution 3% + HA (Hypertonic) Inhalation solution. MD (lla) MDD 5 ml
Saline Solution 7% + HA (Hypertonic) Inhalation solution. MD (lla) MDD 5 ml
Product Therapeutic area License Format
Isotonic Saline Solution 0.9% Nebulization / Inhalation MD (IIa) 5 ml
Isotonic Saline Solution 0.9% + Hyaluronic Acid Nebulization / Inhalation MD (IIa) 5 ml
Hypertonic Saline Solution 1.5% Nebulization / Inhalation MD (IIa) 5 ml
Hypertonic Saline Solution 3% Nebulization / Inhalation MD (IIa) 5 ml
Hypertonic Saline Solution 3% + Hyaluronic Acid Nebulization / Inhalation MD (IIa) 5 ml
Hypertonic Saline Solution 5% Nebulization / Inhalation MD (IIa) 5 ml
Hypertonic Saline Solution 7% + Hyaluronic Acid Nebulization / Inhalation MD (IIa) 5 ml